QV Bioelectronics CEO Dr Chris Bullock Gives Evidence as an Industry Expert to the All-Party Parliamentary Group on Brain Tumours (APPGBT)
The All-Party Parliamentary Group on Brain Tumours (APPGBT) held a fifth oral evidence session today as part of its ongoing inquiry, Pathway to…Read More
QV Bioelectronics Awarded £630,000 Under Innovate UK Biomedical Catalyst Award for implanted electric field therapy device for brain cancer treatment.
Funding will accelerate development of the GRACE implant to treat brain tumour patients with electric field therapy. The project…Read More